Mayne Pharma Group (ASX:MYX) Other Long-Term Liabilities : A$270.0 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Mayne Pharma Group Other Long-Term Liabilities?

Mayne Pharma Group's other long-term liabilities for the quarter that ended in Dec. 2023 was A$270.0 Mil.

Mayne Pharma Group's quarterly other long-term liabilities declined from Dec. 2022 (A$274.4 Mil) to Jun. 2023 (A$260.9 Mil) but then increased from Jun. 2023 (A$260.9 Mil) to Dec. 2023 (A$270.0 Mil).

Mayne Pharma Group's annual other long-term liabilities declined from Jun. 2021 (A$162.2 Mil) to Jun. 2022 (A$108.4 Mil) but then increased from Jun. 2022 (A$108.4 Mil) to Jun. 2023 (A$260.9 Mil).

Mayne Pharma Group Other Long-Term Liabilities Historical Data

The historical data trend for Mayne Pharma Group's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mayne Pharma Group Other Long-Term Liabilities Chart

Mayne Pharma Group Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Mayne Pharma Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Mayne Pharma Group Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Mayne Pharma Group Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Mayne Pharma Group's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Mayne Pharma Group (ASX:MYX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mayne Pharma Group Ltd (ASX:MYX) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

MAYNF:USA HG6:Germany

Address

1538 Main North Road, Salisbury South, Salisbury, SA, AUS, 5106

Website

http://www.maynepharma.com

Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Branded Products (BPD) and Portfolio Products Division (PPD). The Portfolio Products Division distributes dermatology products (branded and generic) in the US on a portfolio basis, The Branded Products Division distributes branded women's health products in the US. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.